Endometrioid adenocarcinoma arising in endometriosis foci six years after estrogen replacement therapy: a case report

We present a case of a 53-year-old woman who developed an endometrioid adenocarcinoma six years after total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO), who was on estrogenic-only hormone replacement therapy (HRT).

Saved in:
Bibliographic Details
Published inEuropean journal of gynaecological oncology Vol. 25; no. 2; p. 255
Main Authors Areia, A, Sousa, V, Frutuoso, C, Dias, I, Martins, M I, de Oliveira, C F
Format Journal Article
LanguageEnglish
Published Italy 2004
Subjects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Carcinoma, Endometrioid - complications
Carcinoma, Endometrioid - diagnosis
Carcinoma, Endometrioid - drug therapy
Carcinoma, Endometrioid - secondary
Cisplatin - administration & dosage
Diagnosis, Differential
Doxorubicin - administration & dosage
Endometriosis - pathology
Female
Humans
Middle Aged
Rectal Neoplasms - diagnosis
Rectal Neoplasms - drug therapy
Rectal Neoplasms - secondary
Urinary Bladder Neoplasms - diagnosis
Urinary Bladder Neoplasms - drug therapy
Urinary Bladder Neoplasms - secondary
Uterine Hemorrhage - etiology
Vaginal Neoplasms - complications
Vaginal Neoplasms - diagnosis
Vaginal Neoplasms - drug therapy
Vaginal Neoplasms - pathology
Online AccessGet more information

Cover

More Information
Summary:We present a case of a 53-year-old woman who developed an endometrioid adenocarcinoma six years after total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO), who was on estrogenic-only hormone replacement therapy (HRT).
ISSN:0392-2936